Hua Medicine (Shanghai) Ltd. (HKG:2552)
Hong Kong · Delayed Price · Currency is HKD 3.920
+0.080 (2.08%)
Jul 17, 2025, 9:45 AM HKT
Hua Medicine (Shanghai) Revenue
In the year 2024, Hua Medicine (Shanghai) had annual revenue of 255.89M CNY with 234.02% growth. Hua Medicine (Shanghai) had revenue of 153.23M in the half year ending December 31, 2024, with 770.67% growth.
Revenue
255.89M CNY
Revenue Growth
+234.02%
P/S Ratio
13.87
Revenue / Employee
1.52M CNY
Employees
168
Market Cap
3.78B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.49B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| Innovent Biologics | 10.03B |
| JD Health International | 61.89B |
| Sino Biopharmaceutical | 30.72B |
| WuXi Biologics | 19.87B |
| Akeso | 2.26B |
| CSPC Pharmaceutical Group | 28.99B |